Literature DB >> 19887811

Diagnostic profiles and prescribing patterns in everyday anthroposophic medical practice--a prospective multi-centre study.

Elke Jeschke1, Thomas Ostermann, Manuela Tabali, Angelina Bockelbrink, Claudia M Witt, Stefan N Willich, Harald Matthes.   

Abstract

BACKGROUND: Although anthroposophic medicine has been used for more than 80 years and global interest in complementary treatments is increasing, a comprehensive and long-term description of everyday anthroposophic care is still lacking. Our study aims to evaluate how anthroposophic medicine is practised under everyday conditions.
METHODS: A total of 38 primary-care physicians in Germany participated in this prospective, multi-centre observational study. Prescriptions, diagnoses, and non-pharmacological therapies were reported for each consecutive patient.
RESULTS: In 2005, 95,116 prescriptions for 32,839 patients (56.2% children, 57.3% female) were recorded. The median duration of consultation depended on physician specialization (general practitioners: 9.5 min; paediatricians: 8.1 min). The most frequent single diagnoses were acute upper respiratory tract infections (URTI), otitis media, and bronchitis in children; hypertension, breast cancer, and depressive episodes in adult females; and hypertension, URTI, and asthma in adult males. Anthroposophic remedies accounted for 41.8% of all drugs prescribed. The odds ratio (OR) for receiving an anthroposophic remedy was very high for cancer (OR = 4.5; 95% CI: 4.2-4.8) and >1 for dorsopathies (OR = 1.5; CI: 1.3-1.6), otitis media (OR = 1.3; CI: 1.2-1.3), and URTI (OR = 1.1; CI: 1.1-1.2). Of the 5,289 therapeutic procedures prescribed, 27% were anthroposophic.
CONCLUSION: A broad range of anthroposophic remedies and non-pharmacological therapies are prescribed for a specific set of diseases in everyday anthroposophic practice. Particularly, patients <60 years received anthroposophic care. Our findings will help in the planning and implementation of further studies. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19887811     DOI: 10.1159/000235239

Source DB:  PubMed          Journal:  Forsch Komplementmed        ISSN: 1661-4119


  6 in total

1.  Cost Analysis of Integrative Inpatient Treatment Based on DRG Data: The Example of Anthroposophic Medicine.

Authors:  Jürgen Heinz; Wolfgang Fiori; Peter Heusser; Thomas Ostermann
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-31       Impact factor: 2.629

2.  Pharmacotherapy of elderly patients in everyday anthroposophic medical practice: a prospective, multicenter observational study.

Authors:  Elke Jeschke; Thomas Ostermann; Manuela Tabali; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes
Journal:  BMC Geriatr       Date:  2010-07-21       Impact factor: 3.921

3.  Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Manuela Tabali; Friedemann Schad; Harald Matthes
Journal:  BMC Neurol       Date:  2011-08-08       Impact factor: 2.474

4.  Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Manuela Tabali; Harald Matthes
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-06       Impact factor: 2.629

5.  Medication and falls in elderly outpatients: an epidemiological study from a German Pharmacovigilance Network.

Authors:  Kirsten Heckenbach; Thomas Ostermann; Friedemann Schad; Matthias Kröz; Harald Matthes
Journal:  Springerplus       Date:  2014-08-29

6.  Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network.

Authors:  Harald Johan Hamre; Anja Glockmann; Kirsten Heckenbach; Harald Matthes
Journal:  Drugs Real World Outcomes       Date:  2017-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.